Trial intelligence / Profile preview

ESP vs PVB in Mastectomy

NCT05590559Unknown

Sponsor
Netherlands Cancer Institute
Start
Jun 2021
Primary completion
Dec 2022
Countries
1
01

Overview

Randomised, single-blind trial (2 arms), sponsored by Netherlands Cancer Institute. Primary endpoints: Highest Numerical Rating Score at 1 day and Cumulative Opioid Dose Ratio at 1 day. Status: unknown.

Beyond the preview

Go deeper on NCT05590559.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05590559.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call